PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
Auto Draft
Auto Draft
Elrig
Auto Draft
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

The Impact of Data and Academic Partnerships on Cold Chain Innovation

Cold chain logistics are vital in the pharmaceutical and life sciences industries, where temperature-sensitive products such as vaccines, medications, and biological samples must be transported and stored under strict temperature controls. Ensuring the integrity of these products is essential, as their efficacy often relies on integrity. precise temperature regulation. However, managing the distribution of such sensitive goods presents significant challenges. With growing sustainability demands, the industry is increasingly relying on innovative solutions that reduce carbon emissions while upholding product integrity.

One such solution has been the collaboration between academic institutions and industry stakeholders to optimise cold chain logistics, with a growing focus on sustainability. A notable example is the partnership between Cardiff University’s Business School and Tower Cold Chain (part of Cold Chain Technologies), aimed at utilising academic expertise to enhance operational efficiency while prioritising sustainable practices.

The Environmental Challenges of Cold Chain Logistics in the Pharmaceutical Industry The pharmaceutical industry’s cold chain logistics operations are highly energy-intensive, primarily due to the stringent temperature requirements needed to preserve the efficacy of drugs and biological materials. For example, vaccines typically need to be stored between 2–8°C (35–46°F), while gene therapies and biologics may require sub-zero or even cryogenic temperatures. Maintaining these conditions over long distances and periods can be technologically challenging and environmentally costly.

Traditional cold chain solutions often involve single-use packaging and active cooling systems, which require constant electricity and result in significant waste and carbon emissions. Additionally, the need for global logistics networks exacerbates the environmental impact. The pharmaceutical sector’s increased demand for reliable cold chain logistics, particularly during emergencies like the COVID-19 pandemic, has put further strain on the industry’s environmental footprint.

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC